How Does This Medical Technology Business Operate?
GE Healthcare Technologies Inc sells medical technology used in clinical care and hospital workflows. The business is built around equipment, related solutions, and ongoing customer support tied to installed systems. It operates at large scale, with a public market value of about USD 28.6 billion. The company’s equity trades on NASDAQ.
Are Margins and Cash Flow Holding Steady?
FundamentalsFor 2025 (reported in USD), revenue reached about USD 20.6 billion, alongside EBIT of roughly USD 2.8 billion and net income of about USD 2.2 billion. Revenue grew 4.8% versus the prior year, while trailing profitability sat on a 39.14% gross margin, a 12.63% operating margin, and a 9.10% net margin.
Capital intensity looks modest in the latest year, with depreciation and amortization of about USD 287 million and capital expenditure also at roughly USD 287 million. Operating cash generation after tax and reinvestment was about USD 2.1 billion, with total debt at around USD 508 million. On trailing figures, return on equity was 18.75%.
Is The Stock Fairly Priced Now?
DCF / MultiplesAt USD 62.86 per share, the stock sits near the central fair value estimate of USD 63.77, within a valuation range that runs from USD 40.62 in a weaker scenario to USD 88.40 in a stronger outcome. The pricing also lines up with mid-teens earnings and low-teens EV/EBITDA multiples (15.21x P/E and 12.54x EV/EBITDA on a trailing basis).
Returns Depend On Margin Discipline
TakeawayExecution looks steady, with margins holding up across the year. The case depends on sustaining returns while keeping reinvestment disciplined. If margins slip, returns on capital can fade quickly. If returns stay durable, the current pricing can be carried.